Sampat Ingale

Sampat Ingale is from Greater Boston. Sampat is currently Senior Director of Peptide and Protein Chemistry at Biohaven, located in Cambridge, MA. Sampat also works as Director of Peptide Chemistry at Biohaven, a job Sampat has held since Sep 2023. In Sampat's previous role as a Director of Chemistry at Flagship Pioneering, Sampat worked in Cambridge, Massachusetts, United States until May 2023. Prior to joining Flagship Pioneering, Sampat was a Principal Scientist- Bioconjugation and Peptide Chemsitry at Merck and held the position of Principal Scientist- Bioconjugation and Peptide Chemsitry at Cambridge, Massachusetts. Prior to that, Sampat was a Associate Principal Scientist-Bioconjugation and Peptide Chemistry at Merck from Jun 2017 to Nov 2021. Sampat started working as Senior Research Scientist - Protein and Peptide Chemistry at Novo Nordisk in Seattle, Washington in Dec 2016. From Oct 2015 to Dec 2016, Sampat was Scientist at Sorrento Therapeutics, Inc., based in Greater San Diego Area. Prior to that, Sampat was a Research Associate at The Scripps Research Institute, based in La Jolla, CA from Mar 2013 to Oct 2015. Sampat started working as Senior Manager-Global Discovery at Nycomed Pharma Private Limited in Andheri, Mumbai, India in Apr 2011.